BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 14633242)

  • 1. Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study.
    Alberti A; Sarchielli P; Gallinella E; Floridi A; Floridi A; Mazzotta G; Gallai V
    J Sleep Res; 2003 Dec; 12(4):305-11. PubMed ID: 14633242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome.
    Ciftci TU; Kokturk O; Bukan N; Bilgihan A
    Cytokine; 2004 Oct; 28(2):87-91. PubMed ID: 15381186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome.
    Liu H; Liu J; Xiong S; Shen G; Zhang Z; Xu Y
    J Tongji Med Univ; 2000; 20(3):200-2. PubMed ID: 11215046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine changes after surgical treatment of obstructive sleep apnoea syndrome.
    Constantinidis J; Ereliadis S; Angouridakis N; Konstantinidis I; Vital V; Angouridaki C
    Eur Arch Otorhinolaryngol; 2008 Oct; 265(10):1275-9. PubMed ID: 18317790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of surgical treatment of obstructive sleep apnea syndrome on the plasma TNF-alpha levels.
    Kataoka T; Enomoto F; Kim R; Yokoi H; Fujimori M; Sakai Y; Ando I; Ichikawa G; Ikeda K
    Tohoku J Exp Med; 2004 Dec; 204(4):267-72. PubMed ID: 15572852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of MCP-1 and adiponectin in obstructive sleep apnea syndrome.
    Kim J; Lee CH; Park CS; Kim BG; Kim SW; Cho JH
    Arch Otolaryngol Head Neck Surg; 2010 Sep; 136(9):896-9. PubMed ID: 20855682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaled breath condensate cytokine level as a diagnostic tool for obstructive sleep apnea syndrome.
    Li Y; Chongsuvivatwong V; Geater A; Liu A
    Sleep Med; 2009 Jan; 10(1):95-103. PubMed ID: 18207457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in ghrelin, leptin and pro-inflammatory cytokines after therapy in Obstructive Sleep Apnea Syndrome (OSAS) patients.
    De Santis S; Cambi J; Tatti P; Bellussi L; Passali D
    Otolaryngol Pol; 2015; 69(2):1-8. PubMed ID: 26224223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between inflammatory factors and arrhythmia and heart rate variability in OSAS patients.
    Xie JY; Liu WX; Ji L; Chen Z; Gao JM; Chen W; Chen GF; Zhu Q
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2037-2053. PubMed ID: 32141573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in Serum Adropin, Adiponectin, and Proinflammatory Cytokine Levels in OSAS.
    Celikhisar H; Ilkhan GD
    Can Respir J; 2020; 2020():2571283. PubMed ID: 32454912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between sleep complaints and proinflammatory cytokines in haemodialysis patients.
    Erten Y; Kokturk O; Yuksel A; Elbeg S; Ciftci TU; Pasaoglu H; Ozkan S; Bali M; Arinsoi T; Sindel S
    Nephrology (Carlton); 2005 Aug; 10(4):330-5. PubMed ID: 16109076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea-hypopnea syndrome.
    Imagawa S; Yamaguchi Y; Ogawa K; Obara N; Suzuki N; Yamamoto M; Nagasawa T
    Respiration; 2004; 71(1):24-9. PubMed ID: 14872107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome.
    Ryan S; Taylor CT; McNicholas WT
    Am J Respir Crit Care Med; 2006 Oct; 174(7):824-30. PubMed ID: 16840748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of osteopontin and tumor necrosis factor-α levels with insulin resistance in obese patients with obstructive sleep apnea syndrome.
    Sarac F; Basoglu OK; Gunduz C; Bayrak H; Biray Avci C; Akcicek F
    J Endocrinol Invest; 2011; 34(7):528-33. PubMed ID: 20935448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome.
    Sozer V; Kutnu M; Atahan E; Calıskaner Ozturk B; Hysi E; Cabuk C; Musellim B; Simsek G; Uzun H
    Clin Respir J; 2018 Apr; 12(4):1615-1622. PubMed ID: 28960823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of vitamin D supplemantation on prognosis in patients with mild obstructive sleep apnea syndrome.
    Ayyıldız F; Yıldıran H; Afandiyeva N; Gülbahar Ö; Köktürk O
    Turk J Med Sci; 2021 Oct; 51(5):2524-2533. PubMed ID: 34174792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cardiotrophin-1 and IL-6 levels in patients with obstructive sleep apnea syndrome.
    Kurt OK; Tosun M; Talay F
    Inflammation; 2013 Dec; 36(6):1344-7. PubMed ID: 23783568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive biomarker profiling in patients with obstructive sleep apnea.
    Maeder MT; Strobel W; Christ M; Todd J; Estis J; Wildi K; Thalmann G; Hilti J; Brutsche M; Twerenbold R; Rickli H; Mueller C
    Clin Biochem; 2015 Mar; 48(4-5):340-6. PubMed ID: 25218814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure.
    Yokoe T; Minoguchi K; Matsuo H; Oda N; Minoguchi H; Yoshino G; Hirano T; Adachi M
    Circulation; 2003 Mar; 107(8):1129-34. PubMed ID: 12615790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune function of myeloid-derived suppressor cells and its mechanism in obstructive sleep apnea syndrome].
    Chen SW; Li J; Xiang B; Xu SJ; Wang L
    Zhonghua Yi Xue Za Zhi; 2020 Feb; 100(4):295-300. PubMed ID: 32075359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.